Back to Search
JORDANA WEBER, MD
MD
Family Medicine Physician
NPI: 1174897441IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2023
Research & Publications (20)
Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
PMID 19536884·Cancer·2009
3-trial
The physiology of long-distance migration: extending the limits of endurance metabolism.
PMID 19218508·J Exp Biol·2009
7-preclinical
Hyperalgesia induced by oral stavudine administration to rats does not depend on spinal neuronal cell death, or on spinal or systemic inflammatory cytokine secretion, or metabolic dysregulation.
PMID 19442827·Neurotoxicology·2009
7-preclinical
Unusual spinal arteriovenous dural fistula: digital subtraction and magnetic resonance angiography.
PMID 19636507·Klin Neuroradiol·2009
5-case
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.
PMID 19671877·Clin Cancer Res·2009
3-trial
Ipilimumab: controversies in its development, utility and autoimmune adverse events.
PMID 19198837·Cancer Immunol Immunother·2009
6-review
The lumbar spine in Neanderthals shows natural kyphosis.
PMID 18301930·Eur Spine J·2008
4-observational
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010).
PMID 19001147·Oncologist·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 252 S 4TH ST FL 3
LEBANON, PA 17042 - Phone
- (717) 270-4876
Quick Facts
- NPI
- 1174897441
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile